引用次数
引用: 9,603
H-指数: 42
I10-指数 : 59
出版物: 115
Neuroendocrine modulators of energy balance: perspectives for obesity research.
S. Hofmann , N. Finer , D. Heal , G. Krause
Obesity and metabolic disorders. Fourth Solvay Pharmaceuticals Conference, Venice, Italy, 5-6 October 2003. 161 -172
1
2005
Unimolecular Dual Incretins Maximize Metabolic Benefits in Rodents, Monkeys, and Humans
B. Finan , T. Ma , N. Ottaway , T. D. Muller
Science Translational Medicine 5 ( 209) 1 -17
465
2013
The tumour necrosis factor-alpha induced vascular permeability is associated with a reduction of VE-cadherin expression.
H Grasberger , P Jung , J Vlotides , O E Janssen
European Journal of Medical Research 7 ( 4) 171 -176
50
2002
Regulatory T cells require IL-6 receptor alpha signaling to control skeletal muscle function and regeneration
M Becker , S Joseph , F Garcia-Carrizo , R Zachariah-Tom
EUROPEAN JOURNAL OF IMMUNOLOGY 53 54 -54
2023
Unravelling a role for the orphan G protein coupled receptor 83 in energy metabolism
TD Müller , A Müller , K Habegger , CX Yi
Experimental and Clinical Endocrinology & Diabetes 121 ( 03) OP4_21 -OP4_21
2013
Emerging Function of Fat Mass and Obesity-Associated
TD Müller , MH Tschöp , S Hofmann
2013
Glucose and the regulation of plasminogen-activator inhibitor-1 synthesis in human aortic smooth muscle cells
S Hofmann , H Grasberger , OE Janssen , S Mandel-Weber
DIABETOLOGIA 43 A33 -A33
2000
Effect of glucose on plasminogen activator inhibitor-1 (PAI-1) synthesis in human aortic vascular smooth muscle cells (vSMC)
S Hofmann , H Grasberger , OE Janssen , R Landgraf
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY AND DIABETES 108 S118 -S118
2000
Endothelial cannabinoid receptor CB1 deficiency decreases oxLDL uptake and attenuates vascular inflammation in atherosclerosis
B Chen , R Guillamat Prats , G Li , Y Jansen
Atherosclerosis 355 21 -21
2022
Glucose and cytokine-dependent expression of PDGF receptors (PDGF-Rs) on human vascular endothelium
R Tibes , S Hofmann , R Landgraf
DIABETOLOGIA 43 A73 -A73
2000
936-P: Plasma Proteomic Profiling Delineates Treatment Efficacy of a GLP-1/GIP Coagonist in Female and Male Mice
Susanna M Hofmann , NICOLAI J WEWER ALBRECHTSEN , Matthias H Tschoep , Annette Feuchtinger
Diabetes 69
2020
Melanocortin signaling in the CNS directly regulates circulating cholesterol.
Diego Perez-Tilve , Susanna M Hofmann , Joshua Basford , Ruben Nogueiras
Nature Neuroscience 13 ( 7) 877 -882
80
2010
Dual melanocortin‐4 receptor and GLP‐1 receptor agonism amplifies metabolic benefits in diet‐induced obese mice
Christoffer Clemmensen , Brian Finan , Katrin Fischer , Robby Zachariah Tom
Embo Molecular Medicine 7 ( 3) 288 -298
51
2015
Plasma proteome profiling discovers novel proteins associated with non-alcoholic fatty liver disease.
Lili Niu , Philipp E Geyer , Nicolai J Wewer Albrechtsen , Lise L Gluud
Molecular Systems Biology 15 ( 3)
58
2019
GLP-1-mediated delivery of tesaglitazar improves obesity and glucose metabolism in male mice
Carmelo Quarta , Kerstin Stemmer , Aaron Novikoff , Bin Yang
Nature Metabolism 4 ( 8) 1071 -1083
3
2022
Loss of GIPR in LEPR cells impairs glucose control by GIP and GIP: GLP-1 co-agonism without affecting body weight and food intake in mice
Seun Akindehin , Arkadiusz Liskiewicz , Daniela Liskiewicz , Miriam Bernecker
Molecular Metabolism 83 101915 -101915
2024
Fibroblast Growth Factor 21 Mediates Specific Glucagon Actions
Kirk M Habegger , Kerstin Stemmer , Christine Cheng , Timo D Müller
Diabetes 62 ( 5) 1453 -1463
150
2013
GLP-1/Glucagon Coagonism Restores Leptin Responsiveness in Obese Mice Chronically Maintained on an Obesogenic Diet
Christoffer Clemmensen , Joseph Chabenne , Brian Finan , Lorraine Sullivan
Diabetes 63 ( 4) 1422 -1427
141
2014
Defective Lipid Delivery Modulates Glucose Tolerance and Metabolic Response to Diet in Apolipoprotein E–Deficient Mice
Susanna M Hofmann , Diego Perez-Tilve , Todd M Greer , Beth A Coburn
Diabetes 57 ( 1) 5 -12
79
2008
High-fat-diet exposure induces IgG accumulation in hypothalamic microglia
Chun-Xia Yi , Matthias H Tschöp , Stephen C Woods , Susanna M Hofmann
Disease models & mechanisms 5 ( 5) 686 -690
90
2012